Colon cancer stemness as a reversible epigenetic state: Implications for anticancer therapies

doi:10.4252/wjsc.v11.i11.920

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 11

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8333)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-6) series.

Item

Count

PDF

449

WORD

224

HTML

4086

Figures (1-3)

285

Tables (1-6)

150

Sum=5194

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

488

Download

815

Sum=1303

Publishing Process of This Article

Item

Count

Browse

750

Download

1086

Sum=1836

Nov 26, 2019 (publication date) through May 10, 2024

Times Cited of This Article

Times Cited (15)

Journal Information of This Article

Publication Name

World Journal of Stem Cells

ISSN

1948-0210

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Stem Cells. Nov 26, 2019; 11(11): 920-936
Published online Nov 26, 2019. doi: 10.4252/wjsc.v11.i11.920

Table 5 Positive correlation between combined expression of cancer stem cell markers CD133, CD44 and CD166 and epigenetic readers

Family/gene symbol	Epidrug/chemical probe	Z-score	P value
Methylated DNA binding
MBD1	-	2.593	0.009517
MBD2	-	3.477	0.0005076
ZBTB4	-	5.496	3.89E-08
Methylated histone binders
Zinc finger, PHD-type
DPF3		3.503	0.0004602
Bromodomain	Apabetalone², Bromosporine³
BPTF		2.621	0.008773
BAZ2B	GSK2801³	4.791	1.66E-06
Tudor domain
TDRD1	-	2.459	0.01394
TP53BP1	-	2.965	0.003029
Other cofactors of epigenetic complexes
RBBP5	-	2.966	0.003014
TADA2B	-	3.382	0.0007189
ELP2	PLX-4720³	3.277	0.00105
ELP3	-	2.622	0.00875
TAB2	-	2.551	0.01074
NCOR1	-	3.62	0.0002949
Chromodomain (Chromatin Organization Modifier Domain)
CHD1, CHD3, CHD9	-	3.007/4.099/4.367	< 0.003

¹Approved for the treatment of other diseases;

²Used in clinical trials for other diseases;

³Not yet used in clinical trials.

Citation: Vincent A, Ouelkdite-Oumouchal A, Souidi M, Leclerc J, Neve B, Van Seuningen I. Colon cancer stemness as a reversible epigenetic state: Implications for anticancer therapies. World J Stem Cells 2019; 11(11): 920-936
URL: https://www.wjgnet.com/1948-0210/full/v11/i11/920.htm
DOI: https://dx.doi.org/10.4252/wjsc.v11.i11.920